ShanXi C&Y Pharmaceutical Group Co.,LTD.

¥7.57As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300254Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.96%)
Div yield —
ROE 6.49%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.58
PE TTM 83.76
TSR TTM (32.17%)
Mkt cap ¥1.947B
ROIC 5.69%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.07
19.77%
(58.70%)
Sell 4|0|6|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.08
0.09
8.61%
7.05%
12.77%
15.89%
Revenue¥M
99.25
96.70
99.66
99.78
1.03%
(1.67%)
2.35%
5.19%
Peers (US$291.9M)
Cap (US$)
PE
281.3M
—
294.9M
14.89x
Capital
TTM
5Y
10Y
Leveragex
7.288
0.080
0.077
EBIT/Intx
0.338
0.295
0.304
Own earn%
(1134.19)
(36.13)
(27.51)
Sh yield%
23.11
30.27
30.77
Owners
Insiders/Inst%
10.10
35.38
Short interest%
1.60
SBC / revenue%
3.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–21
$1 testx
—
Incr. ROIC%
17